CD19 and precursor B-cell acute lymphoblastic leukemia: Incredibly, our results demonstrate that, just like EV-CD10+ and EV-CD19+, the double positive EVs (EV-CD10+CD19+) were elevated in B-ALL PB patients at diagnosis, with a 5-fold magnitude of change in relation to the CG (Figures 8A–D).